Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 275 publications
Metachronous Contralateral Recurrence in Upper Tract Urothelial Carcinoma: A Multi-Institutional Competing-Risks Analysis From the ROBUUST 3.0 Registry.
Journal: Urology practice
Published: June 22, 2026
Oncological outcomes of radical nephroureterectomy with or without lymphadenectomy and neoadjuvant therapy in cN+ UTUC: Insights from the ROBUUST registry.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: May 27, 2026
Real-world multicenter adherence to international guidelines in the management of upper tract urothelial carcinoma: insights from the ROBUUST 2.0 Registry.
Journal: Minerva urology and nephrology
Published: April 23, 2026
Impact of Elevated C-Reactive Protein on Survival Outcomes of Patients with Small Renal Masses: A Retrospective Multicenter Analysis.
Journal: Current oncology (Toronto, Ont.)
Published: March 23, 2026
External validation of the preoperative risk evaluation for partial nephrectomy (PREP) score.
Journal: BJUI compass
Published: February 26, 2026
Histology-specific Prognostic Impact of Microscopic Positive Surgical Margins in Renal Cell Carcinoma: Implications for Postoperative Surveillance.
Journal: European urology open science
Published: January 16, 2026
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry.
Journal: Minerva urology and nephrology
Published: December 18, 2025
Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomes.
Journal: World journal of urology
Published: November 19, 2025
Last Updated: 09/26/2026